23560-36-3Relevant articles and documents
Anti-Angiogenic Compounds
-
Paragraph 0137; 0145, (2016/11/24)
Compounds and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age-related macular degeneration, diabetic retinopathy or cancer.
Antiarrhythmic method of use
-
, (2008/06/13)
Pharmaceutical compositions containing as an active ingredient a compound of the formula STR1 wherein R1 is hydrogen or methyl, Ar is phenyl, 2-pyridyl, 6-methyl-2-pyridyl, 2-quinolyl, 1-methyl-benzimidazol-2-yl, 2-pyrazinyl or 3-methyl-isoxazo